share_log

BTIG Initiates Coverage On Xtant Medical Hldgs With Buy Rating, Announces Price Target of $2

BTIG Initiates Coverage On Xtant Medical Hldgs With Buy Rating, Announces Price Target of $2

BTIG以买入评级启动对Xtant Medical Hldgs的保险,宣布目标股价为2美元
Benzinga ·  2023/12/05 08:40

BTIG analyst Ryan Zimmerman initiates coverage on Xtant Medical Hldgs (AMEX:XTNT) with a Buy rating and announces Price Target of $2.

BTIG分析师瑞安·齐默尔曼以买入评级开始对Xtant Medical Hldgs(AMEX: XTNT)进行报道,并宣布目标股价为2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发